Antimicrobial resistance
Microbes evolve to resist drugs that once treated infections.
Antimicrobial resistance (AMR) occurs when microbes evolve mechanisms that protect them from antimicrobials, which are drugs used to treat infections in humans, animals, and plants. Any microbe can develop resistance, including bacteria (antibiotic resistance), viruses (antiviral resistance), parasites (antiparasitic resistance), and fungi (antifungal resistance). Together, these adaptations fall under the AMR umbrella, posing a challenge to all countries and all demographics.
- field
- Public health, microbiology
- key_organization
- World Health Organization (WHO)
Lore & Background
Antimicrobial resistance is a naturally occurring process driven by misuse and improper management of antimicrobials, though it can also occur through genetic mutations and the spread of resistant genes. Misuse and overuse of antimicrobials in medicine and agriculture accelerate resistance development. Microbes resistant to multiple drugs are termed multidrug-resistant (MDR) and are sometimes called superbugs. Antibiotic resistance, a subset of AMR, arises through spontaneous mutation, horizontal gene transfer, and increased selective pressure from antibiotic overuse. Preventive measures such as using narrow-spectrum antibiotics and improving hygiene practices aim to reduce the spread of resistance. The burden of AMR is immense, with nearly 5 million annual deaths associated with resistant infections.
Reader's Guide
Antimicrobial resistance represents a fundamental challenge to modern medicine. Infections from AMR microbes are more challenging to treat and often require costly alternative therapies that may have more severe side effects. Global initiatives, such as calls for international AMR treaties, emphasize coordinated efforts to limit misuse, fund research, and provide access to necessary antimicrobials in developing nations. However, the COVID-19 pandemic redirected resources and scientific attention away from AMR, intensifying the challenge. Without coordinated global action, vital medical procedures like surgery, organ transplants, neonatal care, and cancer treatment could be at risk. Combating AMR requires cooperation among governments, healthcare workers, researchers, pharmaceutical companies, farmers, and the public through responsible antibiotic use, monitoring resistance, limiting antibiotics in animals, and improving access to medicines, vaccines, and tests.
Did You Know?
- Antimicrobial resistance can occur naturally through genetic mutations and the spread of resistant genes.
- Microbes resistant to multiple drugs are termed multidrug-resistant (MDR) and are sometimes called superbugs.
Frequently Asked Questions
Who is Antimicrobial resistance?
AMR is the evolutionary process by which microbes—bacteria, viruses, fungi, and parasites—adapt so that the drugs meant to eliminate them no longer work. It isn't a single pathogen but a broad phenomenon that can arise in any organism exposed to antimicrobial treatment.
What are Antimicrobial resistance's powers/role?
Its core 'ability' is natural selection: microbes that survive a drug exposure pass on the traits that let them do so, gradually making that treatment ineffective. This mechanism operates across all four categories—antibiotics, antivirals, antifungals, and antiparasitics.
How does Antimicrobial resistance's story end?
The arc is still unfolding; there is no fixed finale because new resistance mechanisms keep appearing as new drugs are deployed. The WHO treats it as an ongoing global public-health challenge rather than a narrative with a set conclusion.
Why is Antimicrobial resistance important?
It threatens to undo a century of medical progress by making once-routine infections difficult or impossible to treat, a risk that spans every country and demographic. Without coordinated intervention, everyday medical procedures could once again become life-threatening.
Which organization is the key authority on Antimicrobial resistance?
The World Health Organization (WHO) acts as the primary coordinating body, tracking resistance patterns and issuing guidance that bridges public-health policy and microbiology research worldwide.
More in Respiratory & Infectious Diseases 1-24
Elsewhere in the Respiratory & Infectious Diseases universe
Spotted an error? Know more?
This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record